AAFP backs FDA tentative trans fats determination

AAFP backs FDA tentative trans fats determination

(HealthDay)—The American Academy of Family Physicians (AAFP) has expressed their support for the U.S. Food and Drug Administration's tentative determination regarding partially hydrogenated oils (PHOs) as food additives.

Noting that PHOs have been used in food for many years based on self-determinations that such use is generally safe, Jeffrey J. Cain, M.D., board chair of the AAFP, responded via letter to the FDA's request for comments about the tentative determination regarding PHOs. If the tentative determination is finalized, food manufacturers will no longer be allowed to sell PHOs unless the manufacturer has received FDA approval.

In a literature review, members of the AAFP's Americans in Motion-Healthy Interventions initiative panel found that PHOs contribute to obesity in children and adults, have adverse effects on , increase the risk of , and contribute to insulin resistance.

"The AAFP reviewed the scientific evidence cited and we are pleased to wholeheartedly support the FDA's determination that PHOs are not generally safe for use in food," Cain writes in the letter.

More information: More Information

Related Stories

AAFP to Obama: Family docs key in violence prevention

date Jan 25, 2013

(HealthDay)—Family physicians can play a role in addressing and preventing violence in the community, according to a Jan. 17 letter to President Obama from the American Association of Family Physicians ...

IPAs and PHOs viable option for small independent practices

date Aug 09, 2013

(HealthDay)—For small and medium-size independent practices, sharing care management and information technology resources with other practices through an independent practice association (IPA) or physician-hospital ...

FDA encourages opioid prescribers to pursue training

date Mar 12, 2013

(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according ...

Recommended for you

Teva buying Auspex for $3.2 billion

date 13 hours ago

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

Oral hepatitis B vaccine could become a reality

date 15 hours ago

In a new study, researchers report progress toward perfecting a radical new method of producing vaccines using genetically modified corn. The approach could lead to an oral hepatitis B vaccine that requires no refrigeration ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.